Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AFX9 | ISIN: SE0008040653 | Ticker-Symbol: 47H
Frankfurt
25.04.25
08:06 Uhr
3,635 Euro
-0,200
-5,22 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HUMANA AB Chart 1 Jahr
5-Tage-Chart
HUMANA AB 5-Tage-Chart
RealtimeGeldBriefZeit
3,6453,71011:14
GlobeNewswire (Europe)
2 Leser
Artikel bewerten:
(0)

Humana AB: Humana reports first quarter 2025 results

Finanznachrichten News

Continued profit improvement

Summary of the first quarter

• Net revenue was SEK 2,533 million (2,407), an increase of 5 percent.

• Organic growth was -2.1 percent (-1.0).

• Operating profit was SEK 143m (87).

• Adjusted operating profit was SEK 108m (100), an increase of 8 percent.

• Net profit after tax for the period amounted to SEK 74m (21).

• Earnings per share for the period amounted to SEK 1.44 (0.44).

• Cash flow for the period amounted to SEK 108m (-59).

• Operating cash flow amounted to SEK 156m (110).

Highlights

• Adjusted operating profit during the quarter improved by 8 percent.

• The leverage ratio fell to 2.6x.

• Operating cash flow improved to SEK 156m.

• Continued profitable growth in Norway.

• The elderly care business in Finland was divested for a consideration of EUR 25m, corresponding to approx. SEK 285m.

• As of March 31, 2025, 1,267,357 own shares, corresponding to 2.4 percent of the total shares and votes, were repurchased.

Significant events in the first quarter of 2025

• In January 2025, it was announced that Humana had signed up to the Science Based Targets initiative and committed to work towards scientifically based emissions targets.

• In February 2025, 21 elderly care homes in Finland were divested for a consideration of EUR 25m, corresponding to approx. SEK 285m.

• In February and March 2025, the Board decided to exercise the authority granted to it by the 2024 annual general meeting (AGM) to buy back 2,000,000 shares. As of 31 March 2025, the company's total holding of own shares amounted to 1,267,357 shares, which corresponds to 2.4 percent of the total number of shares and votes. After the buyback during the quarter, the total number of shares excluding the company's own holding is 50,558,701.

• In March 2025, Humana announced its intention to strengthen Group executive management by appointing Jonas Jarborn to the role of Quality and Compliance Director.

• In March 2025, Humana announced a further addition to Group executive management with the appointment of Gabriella Reuterswärd as Chief Marketing Officer.

President and CEO Nathalie Boulas Nilsson comments

" The first quarter of the year showed further improvements in the Group's performance, primarily driven by Norway, where synergy effects and growth led to an increase in margins, although an improvement in profitability in Sweden was also a contributory factor. Our diversified portfolio is promoting stability - the rolling 12-month adjusted operating margin has reached at least 5 percent for the third consecutive quarter. This is despite digital infrastructure investments, which will help ensure that the savings programme we have initiated will have an effect later in the year."

Read the full comment in the report.

Conference call

A webcast will be held on 24 April 2025 at 09:00 CET at which President and CEO Nathalie Boulas Nilsson and CFO Christoffer Herou will present the report and answer questions. If you wish to take part via the webcast, use the following link.

If you wish to participate via conference call, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the conference call.

Registration teleconference

For more information, please contact:

Christoffer Herou
CFO
+46 72 582 86 16, christoffer.herou@humana.se

Ewelina Pettersson
Head of IR
+46 73 074 79 12, ewelina.pettersson@humana.se

This disclosure contains information that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 24-04-2025 08:00 CET.

Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has 23,000 employees in Sweden, Norway, Finland and Denmark providing care for approximately 10,000 individuals and working to achieve the vision "Everyone is entitled to a good life". In 2024, Humana's net revenue was SEK 10,295m. Humana is listed on Nasdaq Stockholm and the company's headquarters are located in Stockholm. Read more about Humana on: https://www.humanagroup.com/


© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.